Free Trial

Canopy Growth (TSE:WEED) Shares Down 2.6% - What's Next?

Canopy Growth logo with Medical background

Key Points

  • Canopy Growth Corp shares fell by 2.6%, trading between C$1.51 and C$1.52, with a significant drop in trading volume at 1,078,346 shares.
  • ATB Capital has downgraded Canopy Growth's price target from C$3.20 to C$1.60, giving the stock an "underperform" rating.
  • Insider selling activity was noted as Director David Angelo Lazzarato sold 15,701 shares at an average price of C$1.68, indicating a potential lack of confidence from company leadership.
  • Want stock alerts on Canopy Growth? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Canopy Growth Corp (TSE:WEED - Get Free Report)'s share price dropped 2.6% on Tuesday . The company traded as low as C$1.51 and last traded at C$1.52. Approximately 1,078,346 shares were traded during mid-day trading, a decline of 41% from the average daily volume of 1,820,001 shares. The stock had previously closed at C$1.56.

Analyst Ratings Changes

Separately, ATB Capital cut their price target on Canopy Growth from C$3.20 to C$1.60 and set an "underperform" rating on the stock in a research note on Tuesday, June 3rd.

Read Our Latest Research Report on Canopy Growth

Canopy Growth Stock Performance

The company has a debt-to-equity ratio of 120.38, a current ratio of 1.39 and a quick ratio of 2.32. The stock has a market capitalization of C$234.87 million, a P/E ratio of -0.21, a price-to-earnings-growth ratio of -0.01 and a beta of 1.79. The company has a fifty day moving average of C$1.77 and a two-hundred day moving average of C$1.98.

Insider Activity at Canopy Growth

In related news, Director David Angelo Lazzarato sold 15,701 shares of the stock in a transaction that occurred on Monday, June 30th. The stock was sold at an average price of C$1.68, for a total value of C$26,307.34. Company insiders own 0.21% of the company's stock.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

See Also

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines